These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37558203)

  • 1. The rare circulating tumor microemboli as a biomarker contributes to predicting early colorectal cancer recurrences after medical treatment.
    Hao YJ; Chang LW; Yang CY; Lo LC; Lin CP; Jian YW; Jiang JK; Tseng FG
    Transl Res; 2024 Jan; 263():1-14. PubMed ID: 37558203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly Correlated Recurrence Prognosis in Patients with Metastatic Colorectal Cancer by Synergistic Consideration of Circulating Tumor Cells/Microemboli and Tumor Markers CEA/CA19-9.
    Chu HY; Yang CY; Yeh PH; Hsu CJ; Chang LW; Chan WJ; Lin CP; Lyu YY; Wu WC; Lee CW; Wu JK; Jiang JK; Tseng FG
    Cells; 2021 May; 10(5):. PubMed ID: 34068719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Values of Circulating microRNA-21 to Predict Early Recurrence in Patients with Colorectal Cancer after Treatments.
    Hao YJ; Yang CY; Chen MH; Chang LW; Lin CP; Lo LC; Huang SC; Lyu YY; Jiang JK; Tseng FG
    J Clin Med; 2022 Apr; 11(9):. PubMed ID: 35566526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy.
    Zhang D; Zhao L; Zhou P; Ma H; Huang F; Jin M; Dai X; Zheng X; Huang S; Zhang T
    Cancer Cell Int; 2017; 17():6. PubMed ID: 28070168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic diagnostic value of circulating tumor cells and tumor markers CEA/CA19-9 in colorectal cancer.
    Cai M; He H; Hong S; Weng J
    Scand J Gastroenterol; 2023 Jan; 58(1):54-60. PubMed ID: 35968572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Preliminary Analysis of Circulating Tumor Microemboli from Breast Cancer Patients during Follow-Up Visits.
    Lai HC; Huang HH; Hao YJ; Lee HL; Wang CC; Ling TY; Wu JK; Tseng FG
    Curr Oncol; 2024 Sep; 31(9):5677-5693. PubMed ID: 39330049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
    Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C
    J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of circulating tumor cells and analysis of clinicopathological factors in liver cancer.
    Cui K; Ou Y; Ning D; Li H; Xi Y; Li S
    J Cancer Res Ther; 2022 Apr; 18(2):452-460. PubMed ID: 35645114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced prognostic value of combined circulating tumor cells and serum carcinoembryonic antigen in patients with colorectal cancer.
    Yang CY; Lin CC; Huang SC; Lu RH; Lo LC; Tseng JY; Tung CY; Lin CH; Jiang JK
    J Chin Med Assoc; 2023 May; 86(5):465-471. PubMed ID: 36821465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer.
    Wang D; Yang Y; Jin L; Wang J; Zhao X; Wu G; Zhang J; Kou T; Yao H; Zhang Z
    J Cancer; 2019; 10(19):4552-4563. PubMed ID: 31528219
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical Significance of Circulating Tumor Microemboli as a Prognostic Marker in Patients with Pancreatic Ductal Adenocarcinoma.
    Chang MC; Chang YT; Chen JY; Jeng YM; Yang CY; Tien YW; Yang SH; Chen HL; Liang TY; Wang CF; Lee EY; Chang YC; Lee WH
    Clin Chem; 2016 Mar; 62(3):505-13. PubMed ID: 26861552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A Rare Case of Extremely High Counts of EpCAM
    Jiang TT; Li HP; Li YC
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 53(4):711-715. PubMed ID: 35871746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbohydrate antigen 242 highly consists with carbohydrate antigen 19-9 in diagnosis and prognosis of colorectal cancer: study on 185 cases.
    Yang XQ; Chen C; Peng CW; Liu SP; Li Y
    Med Oncol; 2012 Jun; 29(2):1030-6. PubMed ID: 21553105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of CD133
    Fang C; Fan C; Wang C; Huang Q; Meng W; Yu Y; Yang L; Hu J; Li Y; Mo X; Zhou Z
    Cancer Med; 2017 Dec; 6(12):2850-2857. PubMed ID: 29105339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumor cells in whole process management of gastrointestinal stromal tumor in a real-life setting.
    Zhang Q; Xu K; Chen M; Miao Y; Wang N; Xu Z; Xu H
    Saudi J Gastroenterol; 2020; 26(3):160-167. PubMed ID: 32386192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor cell enumeration for improved screening and disease detection of patients with colorectal cancer.
    Tsai WS; Hung WS; Wang TM; Liu H; Yang CY; Wu SM; Hsu HL; Hsiao YC; Tsai HJ; Tseng CP
    Biomed J; 2021 Dec; 44(6 Suppl 2):S190-S200. PubMed ID: 35292267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer.
    Yang XQ; Li Y; Chen C; Peng CW; Liu SP; Liu Y
    Med Oncol; 2011 Sep; 28(3):789-95. PubMed ID: 20373053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.
    Abdallah EA; Braun AC; Flores BCTCP; Senda L; Urvanegia AC; Calsavara V; Fonseca de Jesus VH; Almeida MFA; Begnami MD; Coimbra FJF; da Costa WL; Nunes DN; Dias-Neto E; Chinen LTD
    Oncologist; 2019 Sep; 24(9):e854-e863. PubMed ID: 30846515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer.
    Yang XQ; Chen C; Wang FB; Peng CW; Li Y
    Asian Pac J Cancer Prev; 2011; 12(5):1251-6. PubMed ID: 21875276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD47 Expression in Circulating Tumor Cells and Circulating Tumor Microemboli from Non-Small Cell Lung Cancer Patients Is a Poor Prognosis Factor.
    Torres JA; Brito ABC; Silva VSE; Messias IM; Braun AC; Ruano APC; Buim MEC; Carraro DM; Chinen LTD
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.